Correlation Between Royalty Management and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Royalty Management and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royalty Management and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royalty Management Holding and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Royalty Management and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royalty Management with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royalty Management and Mineralys Therapeutics,.
Diversification Opportunities for Royalty Management and Mineralys Therapeutics,
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Royalty and Mineralys is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Royalty Management Holding and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Royalty Management is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royalty Management Holding are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Royalty Management i.e., Royalty Management and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Royalty Management and Mineralys Therapeutics,
Given the investment horizon of 90 days Royalty Management Holding is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Royalty Management Holding is 1.23 times less risky than Mineralys Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1,140 in Mineralys Therapeutics, Common on September 19, 2024 and sell it today you would earn a total of 95.00 from holding Mineralys Therapeutics, Common or generate 8.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Royalty Management Holding vs. Mineralys Therapeutics, Common
Performance |
Timeline |
Royalty Management |
Mineralys Therapeutics, |
Royalty Management and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Royalty Management and Mineralys Therapeutics,
The main advantage of trading using opposite Royalty Management and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royalty Management position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.Royalty Management vs. Visa Class A | Royalty Management vs. Deutsche Bank AG | Royalty Management vs. Dynex Capital |
Mineralys Therapeutics, vs. Ameriprise Financial | Mineralys Therapeutics, vs. Royalty Management Holding | Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. The Coca Cola |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |